Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation

Journal of Molecular and Cellular Cardiology

Volumn 40, Issue 5, 2006, Pages 629-638

  Ozawa, Takuya ^a   Toba, Ken ^a   Kato, Kiminori ^a   Minagawa, Shiro ^a   Saigawa, Takashi ^a   Hanawa, Haruo ^a   Makiyama, Yashiro ^a   Moriyama, Masato ^a   Honma, Kei ichiro ^a   Isoda, Manabu ^a   Hasegawa, Go ^a   Naito, Makoto ^a   Takahashi, Masuhiro ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Angiogenesis; Growth factors; Ischemia

Indexed keywords

ERYTHROPOIETIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BLOOD FLOW; BONE MARROW TRANSPLANTATION; CAPILLARY; CONTROLLED STUDY; ERYTHROID CELL; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTIGENS, CD14; ANTIGENS, CD31; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ERYTHROID CELLS; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; MICE; MICE, INBRED ICR; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC;

ANIMALIA; MURINAE;

EID: 33646117041     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.01.023     Document Type: Article

References (26)

1. Yla-Herttuala S., and Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med. 9 (2003) 694-701
2. Shintani S., Murohara T., Ikeda H., Ueno T., Sasaki K., Duan J., et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103 (2001) 897-903
3. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
4. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8 (2002) 403-409
5. Terada N., Hamazaki T., Oka M., Hoki M., Mastalerz D.M., Nakano Y., et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416 (2002) 542-545
6. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
7. Risau W. Mechanism of angiogenesis. Nature 386 (1997) 671-674
8. Isner J.M. Therapeuric angiogenesis: a new frontier for vascular therapy. Vasc. Med. 1 (1996) 79-87
9. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., et al. Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet 360 (2002) 427-435
10. Takakura N., Huang X.L., Naruse T., Hamaguchi I., Dumont D.J., Yancopoulos G.D., et al. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity 9 (1998) 677-686
11. Tordjman R., Delaire S., Plouet J., Ting S., Gaulard P., Fichelson S., et al. Erythroblasts are a source of angiogenic factors. Blood 97 (2001) 1968-1974
12. Toba K., Hanawa H., Watanabe K., Fuse I., Masuko M., Miyajima S., et al. Erythroid involvement in CD36 deficiency. Exp. Hematol. 29 (2001) 1194-1200
13. Saito M., Hamasaki M., and Shibuya M. Induction of tube formation by angiopoietin-1 in endothelial cell/fibroblast co-culture is dependent on endogenous VEGF. Cancer Sci. 94 (2003) 782-790
14. Toba K., Hanawa H., Fuse I., Sakaue M., Watanabe K., Uesugi Y., et al. Difference in CD22 molecules in human B cells and basophils. Exp. Hematol. 30 (2002) 205-211
15. Hanawa H., Watanabe K., Nakamura T., Ogawa Y., Toba K., Fuse I., et al. Identification of cryptic splice site, exon skipping, and novel point mutation in type I CD36 deficiency. J. Med. Genet. 39 (2002) 286-291
16. Kinnaird T., Stabile E., Burnett M.S., Shou M., Lee C.W., Barr S., et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109 (2004) 1543-1549
17. Iso Y., Suzuki H., Ohmori Y., Hayata T., Sato Y., Tsunoda T., et al. Fraction of injected cells in bone-marrow mononuclear cell implantation in peripheral artery disease. J. Cardiol. 44 Supp I (2004) 373
18. Clark D.E., Smith S.K., Licence D., Evans A.L., and Charnock-Jones D.S. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J. Endocrinol. 159 (1998) 459-467
19. Autiero M., Waltenberger J., Communi D., Kranz A., Moons L., Lambrechts D., et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat. Med. 9 (2003) 936-943
20. Smith K.J., Bleyer A.J., Little W.C., and Sane D.V. The cardiovascular effects of erythropoietin. Cardiovasc. Res. 59 (2003) 538-548
21. Ribatti D., Vacca A., Roccaro A.M., Crivellato E., and Presta M. Erythropoietin as an angiogenic factor. Eur. J. Clin. Invest. 33 (2003) 891-896
22. Tramontano A.F., Muniyappa R., Black A.D., Blendea M.C., Cohen I., Deng L., et al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Bioph Res Co 308 (2003) 990-994
23. Heeschen C., Aicher A., Lehmann R., Fichtlscherer S., Vasa M., Urbich C., et al. Erythropoietin is a potent physiological stimulus for endothelial progenitor cell mobilization. Blood 102 (2003) 1340-1346
24. Orlic D., Kajstura J., Chimanti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. P Natl Acad Sci USA 98 (2001) 10344-10349
25. Kang H.J., Kim H.S., Zhang S.Y., Park K.W., Cho H.J., Koo B.K., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial. Lancet 363 (2004) 751-756
26. Iwakura A., Tabata Y., Miyao M., Ozeki M., Tamura N., Ikai A., et al. Novel method to enhance sternal healing after harvesting bilateral internal thoracic arteries with use of basic fibroblast growth factor. Circulation 102 (2000) 307-311 (III-)